What is NDC 72065-001?

72065-001 is the product NDC for Keveyis (dichlorphenamide), Dichlorphenamide 50 mg/1 tablet, listed with the FDA by Xeris Pharmaceuticals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Xeris Pharmaceuticals, Inc., NDC labeler code 72065. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Keveyis?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Keveyis NDC 72065-001 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)72065-001Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72065-0001Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72065-001-01	7206500010172065000101	100 TABLET in 1 BOTTLE (72065-001-01)Marketed from Dec 13, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Keveyis
Generic name (nonproprietary): dichlorphenamide
Active ingredients: Dichlorphenamide — 50 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Xeris Pharmaceuticals, Inc.NDC labeler code 72065
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 011366
Marketing start: Dec 13, 2021
Listing expires: Dec 31, 2027
Other FDA classes: Carbonic Anhydrase Inhibitors (Mechanism)Sulfonamides (Chemical structure)
Identifiers: Product ID 72065-001_1a581a6b-8813-42ed-8892-21c2341b62c0SPL ID 1a581a6b-8813-42ed-8892-21c2341b62c0SPL set ID d30a87b9-90fb-35b2-e053-2995a90aea2cRxCUI 197594, 1661799UNII VVJ6673MHYUPC 0372065001019
Pharmacologic class: Carbonic Anhydrase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472065000101 followed by a unit qualifier and the quantity

Package 72065-0001-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 4, 2026.

Indications (excerpt from the label)

KEVEYIS is indicated for the treatment of primary hyperkalemic periodic paralysis, primary hypokalemic periodic paralysis, and related variants. KEVEYIS is an oral carbonic anhydrase inhibitor indicated for the treatment of primary hyperkalemic periodic paralysis, primary hypokalemic periodic paralysis, and related variants ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 72065-001

What is NDC 72065-001?: 72065-001 is the product NDC for Keveyis (dichlorphenamide), Dichlorphenamide 50 mg/1 tablet, listed with the FDA by Xeris Pharmaceuticals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Keveyis (Dichlorphenamide).
What is the active ingredient?: Dichlorphenamide.
Who is the labeler?: Xeris Pharmaceuticals, Inc., NDC labeler code 72065. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Keveyis?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Keveyis (Dichlorphenamide) NDC 72065-001